The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, awarded a $146,300,000 Indefinite Delivery Contract (IDC) titled "Simian Vaccine Evaluation Units" to The Administrators of Tulane Educational Fund, doing business as Tulane University. The contract provides comprehensive scientific services, including animal studies, product manufacturing, and specialized support, to advance NIAID's mission of...
The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the Department of Health and Human Services, awarded a single-award Indefinite Delivery Contract (IDC) valued at $146,300,000 to The Administrators of the Tulane Educational Fund, doing business as Tulane University. The contract covers a 7-year ordering period and aims to provide preclinical research support services to facilitate the development of medical countermeasures, including animal studies,...
The National Institute of Allergy and Infectious Diseases (NIAID) has awarded a single-award, $146.3M Indefinite Delivery Contract to Trustees of Tufts College, doing business as Tufts University School of Medicine, to provide pre-clinical research and development services related to infectious disease models. The contract has a 7-year ordering period and aims to support NIAID's Division of Microbiology and Infectious Diseases in developing and refining animal and animal replacement models for...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded this $146.3 million single award Indefinite Delivery Contract to the University of Louisville to provide preclinical models of infectious diseases over a 7-year ordering period ending in 2031. The contract supports NIAID's mission to facilitate research on understanding, treating, and preventing infectious diseases by enabling the development and refinement of small animal, non-human primate, and non-traditional animal...
The federal agency National Institute of Allergy and Infectious Diseases (NIAID) awarded an Indefinite Delivery Contract (IDC) with a ceiling value of $40,000,000 to Louisiana State University (LSU) to provide pre-clinical models of infectious diseases. This multiple award IDC has an ultimate completion date of July 13, 2024. Under this contract, LSU will conduct research, testing, and other services related to pre-clinical models of infectious diseases. This includes providing animal disease...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a single-award Indefinite Delivery Contract (IDC) worth up to $146.3M to the University of South Alabama to provide pre-clinical models of infectious diseases. The contract has a 7-year ordering period ending on July 14, 2031. The IDC comprises four task areas focused on developing and refining small animal, non-human primate, and non-traditional/animal replacement models to evaluate candidate countermeasures (e.g....
This Indefinite Delivery Contract (IDC) award from the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to the University of Louisiana at Lafayette (ULL) supports preclinical evaluation of HIV/AIDS vaccines and prevention strategies through nonhuman primate research. The $66.4 million IDC, with a performance period from April 2020 to March 2027, has no set-aside designation. Under this IDC, NIAID has issued multiple task orders to ULL, valued at over $14 million,...
The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, awarded a single-award Indefinite Delivery Contract valued up to $146,300,000 to Southern Research Institute, a non-profit research organization, to develop and employ animal and animal replacement models of infectious diseases. The contract will support screening, product evaluation, and eventual clinical evaluation of vaccines, therapeutics, and...
The National Institute of Allergy and Infectious Diseases (NIAID) has awarded a single-award, $146.3 million Indefinite Delivery Contract (IDC) to The Research Foundation For The State University Of New York to develop and employ animal and animal replacement models of infectious diseases for screening, product evaluation, and eventual clinical evaluation. This IDC contains four task areas: Task Area A - Small Animal Models of Infectious Diseases Task Area B - Non-Human Primate Models of...
This indefinite delivery contract (IDC) was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, to Saint Louis University, a private, non-profit educational institution. The $146.3 million single-award contract has a 7-year ordering period and supports pre-clinical models of infectious diseases across 4 task areas: A) Small animal models, B) Non-human primate models, C) Animal replacement and non-traditional...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded Tulane University, a private university located in New Orleans, Louisiana, an Indefinite Delivery Contract (IDC) valued at up to $40 million under the "NIAID Preclinical Models of Infectious Diseases 2017-2024" master contract vehicle. This multiple award IDC covers a range of preclinical development support services, including animal model studies, product manufacturing, and scientific/quality services, to facilitate future procurements aligned with NIAID's infectious disease research priorities.
Under this IDC, NIAID has issued several delivery orders to Tulane, including a $1.37 million award to evaluate monovalent vaccines against Venezuelan equine encephalitis and eastern equine encephalitis in nonhuman primate models, and a $7.7 million award to develop and utilize a nonhuman primate model of SARS-CoV-2 infection. As the prime contractor, Tulane will conduct this research at its facilities in New Orleans. These task orders support NIAID's mission to advance medical countermeasures and better understand emerging infectious diseases through preclinical studies and animal model development.